Jane Street’s Lisata Therapeutics LSTA Stock Holding History

Jane Street’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63.7K	Buy	+18,741	New	+$66.7K	﹤0.01%	10829
2022 Q3	–	Sell	-1,144	Closed	-$9K	–	10124
2022 Q2	$9K	Buy	1,144 +33	+3%	+$272	﹤0.01%	9333
2022 Q1	$12K	Sell	1,111 -348	-24%	-$3.98K	﹤0.01%	10040
2021 Q4	$18K	Buy	+1,459	New	+$22.5K	﹤0.01%	9820
2020 Q3	–	Sell	-719	Closed	-$19K	–	7591
2020 Q2	$19K	Buy	+719	New	+$21.2K	﹤0.01%	6971
2014 Q3	–	Sell	-573	Closed	-$560K	–	2850
2014 Q2	$560K	Buy	573 +158	+38%	+$154K	0.01%	1314
2014 Q1	$439K	Buy	+415	New	+$450K	﹤0.01%	1690

Other funds holding LSTA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Jane Street's LSTA Position: Q2 2026 in Review

Jane Street opened a new position in Lisata Therapeutics (LSTA) in Q2 2026: 18,741 shares worth $63.7K. The stake represents ﹤0.01% of the portfolio and ranks #10829 among its holdings. This is a return to the name: Jane Street previously reported a position in LSTA as recently as Q2 2022.

Jane Street first reported a position in LSTA in Q1 2014 and has held it in 7 quarters since. The position peaked at $560K in Q2 2014. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

Jane Street held 18,741 shares of Lisata Therapeutics worth $63.7K as of Q2 2026.
Lisata Therapeutics was a new Jane Street position in Q2 2026.
Lisata Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10829 holding.
Jane Street first reported a position in Lisata Therapeutics in Q1 2014 and has held it in 7 quarters since.
Jane Street's Lisata Therapeutics position peaked at $560K in Q2 2014.
31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.